Search the collection

Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 1
ArticlesPeer ReviewedFull Text
Updated efficacy of avelumab in patients with previously treated metastatic Merkel cell carcinoma after ≥1 year of follow-up: JAVELIN Merkel 200, a phase 2 clinical trial
Author / Creator:Kaufman, Howard L ; Russell, Jeffery S ; Hamid, Omid ; Bhatia, Shailender ; Terheyden, Patrick ; D'Angelo, Sandra P ; Shih, Kent C ; Lebbé, Céleste ; Milella, Michele ; Brownell, Isaac ; Lewis, Karl D ; Lorch, Jochen H ; von Heydebreck, Anja ; Hennessy, Meliessa ; Nghiem, Paul
Publisher:England: BioMed Central Ltd
Journal title:Journal for immunotherapy of cancer, 2018-01, Vol.6 (1), p.7-7, Article 7
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 2
ArticlesPeer ReviewedFull Text
Update on the psychometric properties and minimal important difference (MID) thresholds of the FACT-M questionnaire for use in treatment-naïve and previously treated patients with metastatic Merkel ce...
Author / Creator:Bharmal, Murtuza ; Nolte, Sandra ; Henry-Szatkowski, Mickaël ; Hennessy, Meliessa ; Schlichting, Michael
Publisher:England: BioMed Central
Journal title:Health and quality of life outcomes, 2020-05, Vol.18 (1), p.145-145, Article 145
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 3
ArticlesPeer ReviewedFull Text
Early objective response to avelumab treatment is associated with improved overall survival in patients with metastatic Merkel cell carcinoma
Author / Creator:D’Angelo, Sandra P. ; Hunger, Matthias ; Brohl, Andrew S. ; Nghiem, Paul ; Bhatia, Shailender ; Hamid, Omid ; Mehnert, Janice M. ; Terheyden, Patrick ; Shih, Kent C. ; Brownell, Isaac ; Lebbé, Céleste ; Lewis, Karl D. ; Linette, Gerald P. ; Milella, Michele ; Schlichting, Michael ; Hennessy, Meliessa H. ; Bharmal, Murtuza
Publisher:Berlin/Heidelberg: Springer Berlin Heidelberg
Journal title:Cancer Immunology, Immunotherapy, 2019-04, Vol.68 (4), p.609-618
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 4
ArticlesPeer ReviewedFull Text
How to address the challenges of evaluating treatment benefits-risks in rare diseases? A convergent mixed methods approach applied within a Merkel cell carcinoma phase 2 clinical trial
Author / Creator:Bharmal, Murtuza ; Guillemin, Isabelle ; Marrel, Alexia ; Arnould, Benoit ; Lambert, Jérémy ; Hennessy, Meliessa ; Fofana, Fatoumata
Publisher:England: BioMed Central Ltd
Journal title:Orphanet journal of rare diseases, 2018-06, Vol.13 (1), p.95-95, Article 95
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 5
ArticlesPeer ReviewedFull Text
IN-DEPTH SAFETY ANALYSIS OF PHALLCON: A PHASE 3 STUDY COMPARING PONATINIB VERSUS IMATINIB IN NEWLY DIAGNOSED PH+ ALL
Author / Creator:Yee, Sheena ; Aldoss, Ibrahim ; Hennessy, Meliessa ; Vorog, Alexander ; Patel, Niti ; Jabbour, Elias
Publisher:Pittsburgh: Oncology Nursing Society
Journal title:Oncology nursing forum, 2024-03, Vol.51 (2), p.101C-102C
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 6
ArticlesPeer ReviewedFull Text
Nonprogression with avelumab treatment associated with gains in quality of life in metastatic Merkel cell carcinoma
Author / Creator:Kaufman, Howard L ; Hunger, Matthias ; Hennessy, Meliessa ; Schlichting, Michael ; Bharmal, Murtuza
Publisher:England: Future Medicine Ltd
Journal title:Future oncology (London, England), 2018-02, Vol.14 (3), p.255-266
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 7
ArticlesPeer ReviewedFull Text
Evaluation of the potential for QTc prolongation with avelumab
Author / Creator:Vugmeyster, Yulia ; Güzel, Gülseren ; Hennessy, Meliessa ; Loos, Anja H. ; Dai, Haiqing
Publisher:Berlin/Heidelberg: Springer Berlin Heidelberg
Journal title:Cancer chemotherapy and pharmacology, 2019-11, Vol.84 (5), p.1017-1026
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 8
ArticlesPeer ReviewedFull Text
Avelumab Immunotherapy: Management of Adverse Events Associated With New Treatment for Merkel Cell Carcinoma
Author / Creator:Ugolini, Heather ; Bryan, Jennifer ; Hennessy, Meliessa ; Kaufman, Howard L ; D'Angelo, Sandra
Publisher:United States
Journal title:Clinical journal of oncology nursing, 2019-02, Vol.23 (1), p.E1
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 9
ArticlesPeer ReviewedFull Text
Avelumab Immunotherapy
Author / Creator:Ugolini, Heather ; Bryan, Jennifer ; Hennessy, Meliessa ; Kaufman, Howard L ; D'Angelo, Sandra P
Publisher:Pittsburgh: Oncology Nursing Society
Journal title:Clinical journal of oncology nursing, 2019-02, Vol.23 (1), p.E1-E9
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 10
Dissertations & ThesesFull Text
Evaluation of a proposed framework of structure, process and pattern features characteristic of successful quality improvement collaboratives
Author / Creator:Hennessy, Meliessa
Publisher:ProQuest Dissertations & Theses
Date:2009
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 11
ReportsFull Text
How to address the challenges of evaluating treatment benefits-risks in rare diseases? A convergent mixed methods approach applied within a Merkel cell carcinoma phase 2 clinical trial
Author / Creator:Bharmal, Murtuza ; Guillemin, Isabelle ; Marrel, Alexia ; Arnould, Benoit ; Lambert, Jnrnmy ; Hennessy, Meliessa ; Fofana, Fatoumata
Publisher:BioMed Central Ltd
Journal title:Orphanet Journal of Rare Diseases, 2018, Vol.13 (1)
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 12
ReportsFull Text
Updated efficacy of avelumab in patients with previously treated metastatic Merkel cell carcinoma after ≥1 year of follow-up: JAVELIN Merkel 200, a phase 2 clinical trial
Author / Creator:Kaufman, Howard L ; Russell, Jeffery S ; Hamid, Omid ; Bhatia, Shailender ; Terheyden, Patrick ; D'Angelo, Sandra P ; Shih, Kent C ; Lebbn, Cnleste ; Milella, Michele ; Brownell, Isaac ; Lewis, Karl D ; Lorch, Jochen H ; von Heydebreck, Anja ; Hennessy, Meliessa ; Nghiem, Paul
Publisher:BioMed Central Ltd
Journal title:Journal for ImmunoTherapy of Cancer, 2018, Vol.6 (1)
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.

Search the collection

Export record to excel

Export this record

Export record to excel

Updated efficacy of avelumab in patients with previously treated metastatic Merkel cell carcinoma after ≥1 year of follow-up: JAVELIN Merkel 200, a phase 2 clinical trial

Export this record

Export record to excel

Update on the psychometric properties and minimal important difference (MID) thresholds of the FACT-M questionnaire for use in treatment-naïve and previously treated patients with metastatic Merkel ce...

Export this record

Export record to excel

Early objective response to avelumab treatment is associated with improved overall survival in patients with metastatic Merkel cell carcinoma

Export this record

Export record to excel

How to address the challenges of evaluating treatment benefits-risks in rare diseases? A convergent mixed methods approach applied within a Merkel cell carcinoma phase 2 clinical trial

Export this record

Export record to excel

IN-DEPTH SAFETY ANALYSIS OF PHALLCON: A PHASE 3 STUDY COMPARING PONATINIB VERSUS IMATINIB IN NEWLY DIAGNOSED PH+ ALL

Export this record

Export record to excel

Nonprogression with avelumab treatment associated with gains in quality of life in metastatic Merkel cell carcinoma

Export this record

Export record to excel

Evaluation of the potential for QTc prolongation with avelumab

Export this record

Export record to excel

Avelumab Immunotherapy: Management of Adverse Events Associated With New Treatment for Merkel Cell Carcinoma

Export this record

Export record to excel

Avelumab Immunotherapy

Export this record

Export record to excel

Evaluation of a proposed framework of structure, process and pattern features characteristic of successful quality improvement collaboratives

Export this record

Export record to excel

How to address the challenges of evaluating treatment benefits-risks in rare diseases? A convergent mixed methods approach applied within a Merkel cell carcinoma phase 2 clinical trial

Export this record

Export record to excel

Updated efficacy of avelumab in patients with previously treated metastatic Merkel cell carcinoma after ≥1 year of follow-up: JAVELIN Merkel 200, a phase 2 clinical trial

Refine your search